{{Rsnum
|rsid=2413396
|Gene=MYH9
|Chromosome=22
|position=36312039
|Orientation=plus
|GMAF=0.1947
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYH9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 20.4 | 79.6
| HCB | 0.0 | 19.0 | 81.0
| JPT | 0.0 | 9.7 | 90.3
| YRI | 41.5 | 48.3 | 10.2
| ASW | 12.3 | 64.9 | 22.8
| CHB | 0.0 | 19.0 | 81.0
| CHD | 1.8 | 18.3 | 79.8
| GIH | 0.0 | 22.8 | 77.2
| LWK | 21.8 | 66.4 | 11.8
| MEX | 0.0 | 24.1 | 75.9
| MKK | 20.5 | 53.2 | 26.3
| TSI | 1.0 | 22.5 | 76.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15
|OA=1
}}

{{PMID Auto
|PMID=21245129
|Title=Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese
}}

{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}